An update from Monte Rosa Therapeutics ( (GLUE)) is now available. Effective January 7, 2026, Monte Rosa Therapeutics, Inc. terminated the sales agreement prospectus tied to its at-the-market equity ...
To use JavaDowngrader as a library in your application, check out the Usage (As a library) section. If you just want to downgrade .jar files you can check out the Usage (Standalone) section. To ...
Fuelcell Energy ( (FCEL)) has shared an announcement. On December 30, 2025, FuelCell Energy amended its Open Market Sale Agreement with a syndicate of sales agents including Jefferies, B. Riley ...
The program will remain effective until either all shares are issued and sold or until October 17, 2027, unless terminated earlier. The ATM program was established through a distribution agreement ...
TORONTO--(BUSINESS WIRE)-- Cybin Inc. (CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to advancing mental healthcare by developing new and innovative ...
SAB Biotherapeutics ( (SABS)) has provided an update. On December 29, 2025, SAB Biotherapeutics, Inc. entered into a new sales agreement with UBS Securities LLC to establish an at-the-market equity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results